Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism.
Level 4 - case-series / case-control
Case-control laboratory tissue study
PubMed 19088158 · doi:10.1210/jc.2008-2218
What was done
Steroidogenic enzyme activities synthesizing and inactivating 17beta-estradiol were measured by HPLC in matched eutopic and ectopic tissue from 14 patients with endometriosis and endometrium from 20 control subjects. Expression of the estrogen-responsive gene TFF1 mRNA was also measured.
What was found
The abstract reports directional findings without numerical values or exact p-values: - Aromatase activity was negligible in ectopic endometrium. - Estrogen sulfatase activity was high but did not differ between ectopic, eutopic, and control endometrium. - 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity converting estrone into 17beta-estradiol was higher in ectopic compared to eutopic endometrium. - 17beta-HSD activity converting 17beta-estradiol back to estrone was significantly lower in ectopic tissue compared to eutopic endometrium of both patients and controls. - The activity ratio of synthesizing to inactivating 17beta-HSDs was significantly higher in ectopic lesions. - TFF1 mRNA levels were elevated in all ectopic compared to eutopic samples.
Why it matters
This study shows that local estrogen accumulation in endometriosis lesions is primarily driven by deficient 17beta-estradiol inactivation via altered 17beta-HSD metabolism rather than local aromatase activity.
Limits
Small sample size (14 patients, 20 controls). The abstract reports no numerical values, variances, or effect sizes, and tissue assays ex vivo may not fully capture in vivo hormone dynamics.
Cited by
- supports Ectopic endometriosis implants produce their own local estrogen.